Probiotics and atopic dermatitis: An overview

Frontiers in Microbiology

Volumn 7, Issue APR, 2016, Pages

  Rather, Irfan A ^a   Bajpai, Vivek K ^a   Kumar, Sanjay ^b   Lim, Jeongheui ^c   Paek, Woon K ^c   Park, Yong Ha ^a  

^a Yeungnam University   (South Korea)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c National Science Museum   (South Korea)

Author keywords

Atopic dermatitis; Clinical trials; Inflammation; Probiotics; Skin diseases

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; PROBIOTIC AGENT; THYMIC STROMAL LYMPHOPOIETIN;

ANIMAL MODEL; ATOPIC DERMATITIS; CELL DIFFERENTIATION; DISEASE SEVERITY; ECZEMA; FOOD ALLERGY; GENE MUTATION; GENETIC PREDISPOSITION; HYPERSENSITIVITY; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; MOUSE; NONHUMAN; PREGNANCY DIABETES MELLITUS; PREVALENCE; SHORT SURVEY;

EID: 84966391976     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00507     Document Type: Review

References (98)

1. Adams, C. A. (2010). The probiotic paradox: live and dead cells are biological response modifiers. Nutr. Res. Rev. 23, 37-46.
2. Allen, S. J., Jordan, S., Storey, M., Thornton, C. A., Gravenor, M. B., Garaiova, I., et al. (2014). Probiotics in the prevention of eczema: a randomised controlled trial. Arch. Dis. Child. 99, 1014-1019. doi: 10.1136/archdischild-2013-305799.
3. Batchelor, J. M., Grindlay, D. J., and Williams, H. C. (2010). What's new in atopic eczema? An analysis of systematic reviews published in 2008 and 2009. Clin. Exp. Dermatol. 35, 823-827. doi: 10.1111/j.1365-2230.2010.03901.x.
4. Bertelsen, R. J., Brantsæter, A. L., Magnus, M. C., Haugen, M., Myhre, R., Jacobsson, B., et al. (2014). Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases. J. Allergy Clin. Immunol. 133, 165-171. doi: 10.1016/j.jaci.2013.07.032.
5. Bowcock, A. M., and Cookson, W. O. (2004). The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum. Mol. Genet. 13, R43-R55. doi: 10.1093/hmg/ddh094.
6. Boyle, R. J., Bath-Hextall, F. J., Leonardi-Bee, J., Murrell, D. F., and Tang, M. L. (2008). Probiotics for treating eczema. Cochrane Database Syst. Rev. 8:CD006135. doi: 10.1002/14651858.CD006135.
7. Brouwer, M. L., Wolt-Plompen, S. A., Dubois, A. E., van der Heide, S., Jansen, D. F., Hoijer, M. A., et al. (2006). No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin. Exp. Allergy 36, 899-906. doi: 10.1111/j.1365-2222.2006.02513.x.
8. Carlsten, C., Dimich-Ward, H., Ferguson, A., Watson, W., Rousseau, R., Dybuncio, A., et al. (2013). Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors. Ann. Allergy Asthma Immunol. 110, 24-28. doi: 10.1016/j.anai.2012.10.005.
9. Castro-Rodriguez, J. A. (2010). The Asthma Predictive Index: a very useful tool for predicting asthma in young children. J. Allergy Clin. Immunol. 126, 212-216. doi: 10.1016/j.jaci.2010.06.032.
10. Cebra, J. J. (1999). Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69, 1046-1051.
11. Chapman, C. M., Gibson, G. R., and Rowland, I. (2011). Health benefits of probiotics: are mixtures more effective than single strains? Eur. J. Nutr. 50, 1-17. doi: 10.1007/s00394-010-0166-z.
12. Chernyshov, P. V. (2009). Randomized, placebo-controlled trial on clinical and immunologic effects of probiotic containing Lactobacillus rhamnosus R0011 and L. helveticus R0052 in infants with atopic dermatitis. Microb. Ecol. Health Dis. 21, 228-232. doi: 10.3109/08910600903444234.
13. Cipriani, F., Dondi, A., and Ricci, G. (2014). Recent advances in epidemiology and prevention of atopic eczema. Pediatr. Allergy Immunol. 25, 630-638. doi: 10.1111/pai.12309.
14. Cukrowska, B., Ceregra, A., Klewicka, E., Slizewska, K., Motyl, I., and Libudzisz, Z. (2010). Probiotic Lactobacillus casei and Lactobacillus paracasei strains in treatment of food allergy in children. Prz. Pediatryczny 40, 21-25.
15. Deckers, I. A., McLean, S., Linssen, S., Mommers, M., van Schayck, C. P., and Sheikh, A. (2012). Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS ONE 7:e39803. doi: 10.1371/journal.pone.0039803.
16. Drago, L., Iemoli, E., Rodighiero, V., Nicola, L., De Vecchi, E., and Piconi, S. (2011). Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study. Int. J. Immunopathol. Pharmacol. 24, 1037-1048.
17. Enomoto, T., Sowa, M., Nishimori, K., Shimazu, S., Yoshida, A., Yamada, K., et al. (2014). Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol. Int. 63, 575-585. doi: 10.2332/allergolint.13-OA-0683.
18. Farid, R., Ahanchian, H., Jabbari, F., and Moghiman, T. (2011). Effect of a new synbiotic mixture on atopic dermatitis in children: a randomized-controlled trial. Iran. J. Pediatr. 21, 225-230.
19. Feleszko, W., Jaworska, J., Rha, R. D., Steinhausen, S., Avagyan, A., Jaudszus, A., et al. (2007). Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy 37, 498-505. doi: 10.1111/j.1365-2222.2006.02629.x.
20. Finnbogadóttir, A. F., Árdal, B., Eiríksson, H., Hrafnkelsson, B., Valdimarsson, H., Lúevíksson, B. R., et al. (2012). A long-term follow-up of allergic diseases in Iceland. Pediatr. Allergy Immunol. 23, 181-185. doi: 10.1111/j.1399-3038.2011.01234.x.
21. Fölster-Holst, R., Moises, H. W., Yang, L., Fritsch, W., Weissenbach, J., and Christophers, E. (1998). Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families. Hum. Genet. 102, 236-239. doi: 10.1007/s004390050685.
22. Fölster-Holst, R., Müller, F., Schnopp, N., Abeck, D., Kreiselmaier, I., Lenz, T., et al. (2006). Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br. J. Dermatol. 155, 1256-1261. doi: 10.1111/j.1365-2133.2006.07558.x.
23. Foolad, N., and Armstrong, A. W. (2014). Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children. Benef. Microbes 5, 151-160. doi: 10.3920/BM2013.0034.
24. Forrest, S., Dunn, K., Elliott, K., Fitzpatrick, E., Fullerton, J., McCarthy, M., et al. (1999). Identifying genes predisposing to atopic eczema. J. Allergy Clin. Immunol. 104, 1066-1070. doi: 10.1016/S0091-6749(99)70090-4.
25. Frei, R., Akdis, M., and O'Mahony, L. (2015). Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr. Opin. Gastroenterol. 31, 153-158. doi: 10.1097/MOG.0000000000000151.
26. Gambichler, T., Othlinghaus, N., Tomi, N. S., Holland-Letz, T., Boms, S., Skrygan, M., et al. (2009). Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study. Br. J. Dermatol. 160, 652-658. doi: 10.1111/j.1365-2133.2008.08984.x.
27. Gaskins, H. R. (1997). "Immunological aspects of host/microbiota interactions at the intestinal epithelium, " in Gastrointestinal Microbiology, eds R. I. Mackie, B. A. White, and R. E. Isaacson (New York, NY: International Thomson Publishing), 537-587.
28. Gerasimov, S. V., Vasjuta, V. V., Myhovych, O. O., and Bondarchuk, L. I. (2010). Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, doubleblind, placebo-controlled, clinical trial. Am. J. Clin. Dermatol. 11, 351-361. doi: 10.2165/11531420-000000000-00000.
29. Gobel, R., Larsen, N., Molgaard, C., Jakobsen, M., and Michaelsen, K. F. (2010). Probiotics to young children with atopic dermatitis: a randomized placebo-controlled trial. Int. J. Probiotics Prebiotics 5, 53-60.
30. Gore, C., Custovic, A., Tannock, G., Munro, K., Kerry, G., Johnson, K., et al. (2012). Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clin. Exp. Allergy 42, 112-122. doi: 10.1111/j.1365-2222.2011.03885.x.
31. Grüber, C., Wendt, M., Sulser, C., Lau, S., Kulig, M., Wahn, U., et al. (2007). Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 62, 1270-1276. doi: 10.1111/j.1398-9995.2007.01543.x.
32. Haagerup, A., Bjerke, T., Schiøtz, P. O., Dahl, R., Binderup, H. G., Tan, Q., et al. (2004). Atopic dermatitis-a total genomes can for susceptibility genes. Acta Derm. Venereol. 84, 346-352. doi: 10.1080/00015550410034426.
33. Han, Y., Kim, B., Ban, J., Lee, J., Kim, B. J., Choi, B. S., et al. (2012). A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr. Allergy Immunol. 23, 667-673. doi: 10.1111/pai.12010.
34. Hattori, K., Yamamoto, A., Sasai, M., Taniuchi, S., Kojima, T., Kobayashi, Y., et al. (2003). Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi 52, 20-30.
35. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., et al. (2014). Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506-514. doi: 10.1038/nrgastro.2014.66.
36. Hoffjan, S., and Epplen, J. T. (2005). The genetics of atopic dermatitis: recent findings and future options. J. Mol. Med. 83, 682-692. doi: 10.1007/s00109-005-0672-2.
37. Iemoli, E., Trabattoni, D., Parisotto, S., Borgonovo, L., Toscano, M., Rizzardini, G., et al. (2012). Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J. Clin. Gastroenterol. 46, S33-S40. doi: 10.1097/MCG.0b013e31826a8468.
38. Jan, R. L., Yeh, K. C., Hsieh, M. H., Lin, Y. L., Kao, H. F., Li, P. H., et al. (2012). Lactobacillus gasseri suppresses Th17 pro-inflammatory response and attenuates allergen-induced airway inflammation in a mouse model of allergic asthma. Br. J. Nutr. 108, 130-139. doi: 10.1017/S0007114511005265.
39. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E. (2001). Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079. doi: 10.1016/S0140-6736(00)04259-8.
40. Kawashima, T., Noguchi, E., Arinami, T., Yamakawa-Kobayashi, K., Nakagawa, H., Otsuka, F., et al. (1998). Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J. Med. Genet. 35, 502-504. doi: 10.1136/jmg.35.6.502.
41. Kim, H. J., Kim, H. Y., Lee, S. Y., Seo, J. H., Lee, E., and Hong, S. J. (2013a). Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J. Pediatr. 56, 369-376. doi: 10.3345/kjp.2013.56.9.369.
42. Kim, H. J., Kim, Y. J., Kang, M. J., Seo, J. H., Kim, H. Y., Jeong, S. K., et al. (2012). A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus. Exp. Dermatol. 21, 672-675. doi: 10.1111/j.1600-0625.2012.01539.x.
43. Kim, H. J., Kim, Y. J., Lee, S. H., Kang, M. J., Yu, H. S., Jung, Y. H., et al. (2013b). Effects of Lactobacillus rhamnosus on asthma with an adoptive transfer of dendritic cells in mice. J. Appl. Microbiol. 115, 872-879. doi: 10.1111/jam.12268.
44. Kim, J. Y., Park, B. K., Park, H. J., Park, Y. H., Kim, B. O., and Pyo, S. (2013). Atopic dermatitis-mitigating effects of new Lactobacillus strain, Lactobacillus sakei probio 65 isolated from Kimchi. J. Appl. Microbiol. 115, 517-526. doi: 10.1111/jam.12229.
45. Kim, S. O., Ah, Y. M., Yu, Y. M., Choi, K. H., Shin, W. G., and Lee, J. Y. (2014). Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Ann. Allergy Asthma Immunol. 113, 217-226. doi: 10.1016/j.anai.2014.05.021.
46. Kirjavainen, P. V., Salminen, S. J., and Isolauri, E. (2003). Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J. Pediatr. Gastroenterol. Nutr. 36, 223-227. doi: 10.1097/00005176-200302000-00012.
47. Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., et al. (2007). Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 119, 192-198. doi: 10.1016/j.jaci.2006.09.009.
48. Kwon, H. K., Lee, C. G., So, J. S., Chae, C. S., Hwang, J. S., Sahoo, A., et al. (2010). Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. U.S.A. 107, 2159-2164. doi: 10.1073/pnas.0904055107.
49. Lee, J., Seto, D., and Bielory, L. (2008). Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J. Allergy Clin. Immunol. 121, 116-121. doi: 10.1016/j.jaci.2007.10.043.
50. Lee, Y. A., Wahn, U., Kehrt, R., Tarani, L., Businco, L., Gustafsson, D., et al. (2000). A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat. Genet. 26, 470-473. doi: 10.1038/82625.
51. Leung, D. Y., and Bieber, T. (2003). Atopic dermatitis. Lancet 361, 151-160. doi: 10.1016/S0140-6736(03)12193-9.
52. Leung, D. Y. M. (2003). Infection in atopic dermatitis. Curr. Opin. Pediatr. 15, 399-404. doi: 10.1097/00008480-200308000-00008.
53. Lio, P. A., Lee, M., LeBovidge, J., Timmons, K. G., and Schneider, L. (2012). Clinical management of atopic dermatitis: practical highlights and updates from the atopic dermatitis practice parameter. J. Allergy Clin. Immunol. Pract. 2, 361-369. doi: 10.1016/j.jaip.2014.02.015.
54. Majamaa, H., and Isolauri, E. (1997). Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99, 179-185. doi: 10.1016/S0091-6749(97)70093-9.
55. Majoie, I. M., Oldhoff, J. M., van Weelden, H., Laaper-Ertmann, M., Bousema, M. T., Sigurdsson, V., et al. (2009). Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J. Am. Acad. Dermatol. 60, 77-84. doi: 10.1016/j.jaad.2008.08.048.
56. Marenholz, I., Nickel, R., Rüschendorf, F., Schulz, F., Esparza-Gordillo, J., Kerscher, T., et al. (2006). Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J. Allergy Clin. Immunol. 118, 866-871. doi: 10.1016/j.jaci.2006.07.026.
57. Margolis, D. J., Gupta, J., Apter, A. J., Ganguly, T., Hoffstad, O., Papadopoulos, M., et al. (2013). Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. J. Allergy Clin. Immunol. 133, 784-789. doi: 10.1016/j.jaci.2013.09.015.
58. Martinez, F. D. (2001). The coming-of-age of the hygiene hypothesis. Respir. Res. 2, 129-132. doi: 10.1186/rr48.
59. Matsumoto, M., Aranami, A., Ishige, A., Watanabe, K., and Benno, Y. (2007). LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis. Clin. Exp. Allergy 37, 358-370. doi: 10.1111/j.1365-2222.2007.02642.x.
60. Meninghin, F., Fabiano, V., Mameli, C., and Zuccotti, G. V. (2012). Probiotics and atopic dermatitis in children. Pharmaceuticals 5, 727-744. doi: 10.3390/ph5070727.
61. Mikael, H. (2013). Probiotics and prebiotics in preventing food allergy and eczema. Curr. Opin. Allergy Clin. Immunol. 13, 280-286. doi: 10.1097/ACI.0b013e328360ed66.
62. Michail, S. K., Stolfi, A., Johnson, T., and Onady, G. M. (2008). Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann. Allergy Asthma Immunol. 101, 508-516. doi: 10.1016/S1081-1206(10)60290-6.
63. Morgan, A. R., Han, D. Y., Wickens, K., Barthow, C., Mitchell, E. A., Stanley, T. V., et al. (2014). Differential modification of genetic susceptibility to childhood eczema by two probiotics. Clin. Exp. Allergy 44, 1255-1265. doi: 10.1111/cea.12394.
64. Niccoli, A. A., Artesi, A. L., Candio, F., Ceccarelli, S., Cozzali, R., Ferraro, L., et al. (2014). Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis. J. Clin. Gastroenterol. 48, S34-S36. doi: 10.1097/MCG.0000000000000233.
65. Ouwehand, A. C., Salminen, S., and Isolauri, E. (2002). Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82, 279-289. doi: 10.1023/A:1020620607611.
66. Palmer, C. N., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., et al. (2006). Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38, 441-446. doi: 10.1038/ng1767.
67. Park, C. W., Youn, M., Jung, Y. M., Kim, H., Jeong, Y., Lee, H. K., et al. (2008). New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse. J. Med. Food 11, 405-412. doi: 10.1089/jmf.2007.0144.
68. Passeron, T., Lacour, J. P., Fontas, E., and Ortonne, J. P. (2006). Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 61, 431-437. doi: 10.1111/j.1398-9995.2005.00956.x.
69. Pessi, T., Sutas, Y., Hurme, M., and Isolauri, E. (2000). Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 30, 1804-1808. doi: 10.1046/j.1365-2222.2000.00948.x.
70. Rautava, S., Kainonen, E., Salminen, S., and Isolauri, E. (2012). Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J. Allergy Clin. Immunol. 130, 1355-1360. doi: 10.1016/j.jaci.2012.09.003.
71. Roessler, A., Friedrich, U., Vogelsang, H., Bauer, A., Kaatz, M., Hipler, U. C., et al. (2008). The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin. Exp. Allergy 38, 93-102.
72. Romagnani, S. (2000). T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85, 9-18. doi: 10.1016/S1081-1206(10)62426-X.
73. Romagnani, S., Maggi, E., Parronchi, P., Macchia, D., Piccinni, M. P., and Ricci, M. (1991). Increased numbers of Th2-like CD4+ T cells in target organs and in the allergen-specific repertoire of allergic patients. Possible role of IL-4 produced by non-T cells. Int. Arch. Allergy Appl. Immunol. 94, 133-136. doi: 10.1159/000235344.
74. Rosenfeldt, V., Benfeldt, E., Nielsen, S. D., Michaelsen, K. F., Jeppesen, D. L., Valerius, N. H., et al. (2003). Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111, 389-395. doi: 10.1067/mai.2003.389.
75. Sandilands, A., Terron-Kwiatkowski, A., Hull, P. R., O'Regan, G. M., Clayton, T. H., Watson, R. M., et al. (2007). Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat. Genet. 39, 650-654. doi: 10.1038/ng2020.
76. Savilahti, E., Kuitunen, M., and Vaarala, O. (2008). Pre and probiotics in the prevention and treatment of food allergy. Curr. Opin. Allergy Clin. Immunol. 8, 243-248. doi: 10.1097/ACI.0b013e3282ffb134.
77. Schmidt-Weber, C. B., and Blaser, K. (2004). Immunological mechanisms in specific immunotherapy. Springer Semin. Immunopathol. 25, 377-390. doi: 10.1007/s00281-003-0147-x.
78. Schmitt, J., Schäkel, K., Fölster-Holst, R., Bauer, A., Oertel, R., Augustin, M., et al. (2010). Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Br. J. Dermatol. 162, 661-668. doi: 10.1111/j.1365-2133.2009.09561.x.
79. Servin, A. L., and Coconnier, M. H. (2003). Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract. Res. Clin. Gastroenterol. 17, 741-754. doi: 10.1016/S1521-6918(03)00052-0.
80. Shaw, T. E., Currie, G. P., Koudelka, C. W., and Simpson, E. L. (2011). Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J. Invest. Dermatol. 131, 67-73. doi: 10.1038/jid.2010.251.
81. Silverberg, J. I., and Simpson, E. L. (2013). Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr. Allergy Immunol. 24, 476-486. doi: 10.1111/pai.12095.
82. Sistek, D., Kelly, R., Wickens, K., Stanley, T., Fitzharris, P., and Crane, J. (2006). Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin. Exp. Allergy 36, 629-633. doi: 10.1111/j.1365-2222.2006.02485.x.
83. Strachan, D. P. (1989). Hay fever, hygiene, and household size. BMJ 299, 1259-1260. doi: 10.1136/bmj.299.6710.1259.
84. Strachan, D. P. (2000). Family size, infection and atopy: the first decade of the "hygiene hypothesis." Thorax 55, S2-S10. doi: 10.1136/thorax.55.suppl_1.S2.
85. Strachan, D. P., Aït-Khaled, N., Foliaki, S., Mallol, J., Odhiambo, J., Pearce, N., et al. (2015). Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood. Clin. Exp. Allergy 45, 126-136. doi: 10.1111/cea.12349.
86. van der Aa, L. B., Heymans, H. S., van Aalderen, W. M., Sillevis Smitt, J. H., Knol, J., Ben Amor, K., et al. (2010). Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clin. Exp. Allergy 40:795-804. doi: 10.1111/j.1365-2222.2010.03465.x.
87. Viljanen, M., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., et al. (2005). Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60, 494-500. doi: 10.1111/j.1398-9995.2004.00514.x.
88. Wang, I. J., and Wang, J. Y. (2015). Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin. Exp. Allergy 45, 779-787. doi: 10.1111/cea.12489.
89. Weiss, G., Christensen, H. R., Zeuthen, L. H., Vogensen, F. K., Jakobsen, M., and Frøkiær, H. (2011). Lactobacilli and bifidobacteria induce differential interferon-β profiles in dendritic cells. Cytokine 56, 520-530. doi: 10.1016/j.cyto.2011.07.024.
90. Weston, S., Halbert, A., Richmond, P., and Prescott, S. L. (2005). Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch. Dis. Child. 90, 892-897. doi: 10.1136/adc.2004.060673.
91. Wickens, K., Black, P., Stanley, T. V., Mitchell, E., Barthow, C., Fitzharris, P., et al. (2012). A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin. Exp. Allergy 42, 1071-1079. doi: 10.1111/j.1365-2222.2012.03975.x.
92. Wickens, K., Black, P. N., Stanley, T. V., Mitchell, E., Fitzharris, P., Tannock, G. W., et al. (2008). A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 122, 788-794. doi: 10.1016/j.jaci.2008.07.011.
93. Williams, H., and Flohr, C. (2006). How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J. Allergy Clin. Immunol. 118, 209-213. doi: 10.1016/j.jaci.2006.04.043.
94. Williams, H. C., and Grindlay, D. J. (2008). What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007. Clin. Exp. Dermatol. 33, 685-688. doi: 10.1111/j.1365-2230.2008.02906.x.
95. Woo, S. I, Kim, J. Y., Lee, Y. J., Kim, N. S., and Hahn, Y. S. (2010). Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Ann. Allergy Asthma Immunol. 104, 343-348. doi: 10.1016/j.anai.2010.01.020.
96. Wu, K. G., Li, T. H., and Peng, H. J. (2011). Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety. Br. J. Dermatol. 166, 129-136. doi: 10.1111/j.1365-2133.2011.10596.x.
97. Yesilova, Y., Calka, O., Akdeniz, N., and Berktas, M. (2012). Effect of probiotics on the treatment of children with atopic dermatitis. Ann. Dermatol. 24, 189-193. doi: 10.5021/ad.2012.24.2.189.
98. Yoshida, Y., Seki, T., Matsunaka, H., Watanabe, T., Shindo, M., and Yamada, N. (2010). Clinical effects of probiotic Bifidobacterium breve supplementation in adult patients with atopic dermatitis. Yonago Acta Med. 53, 37-45.